Cord blood transplants are known to tolerate genetic mismatches better than other donor sources. But one specific HLA pairing may sharply raise the risk of severe...
Discover how the first FDA-cleared blood test for Alzheimerโs disease, developed by Fujirebio, is transforming early detection and diagnosis. This breakthrough not only simplifies screening but also brings huge economic and clinical valueโespecially amid shrinking federal funding for Alzheimerโs...
Donation after circulatory death now accounts for nearly half of all deceased organ donors in the United States. Advances in preservation technology are helping make more...